Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments and Fair Value Measurements (Tables)

v3.21.2
Financial Instruments and Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of fair value, assets and liabilities measured on recurring basis
The Company's assets and liabilities measured or disclosed at fair value were as follows:
Fair value measurements at September 30, 2021 using
(in millions) Total Quoted prices
in active
markets for
identical
assets
(Level 1)		 Significant
other
observable
inputs
(Level 2)		 Significant
unobservable
inputs
(Level 3)
Current assets:
    Cash equivalents $ 150  150  —  — 
    Financial instrument asset (note 5)
92  —  92  — 
Current liabilities:
     Debt (note 5) 549  —  549  — 
     Interest rate swap arrangements (note 5) 2  —  2  — 
Long-term liabilities:
Debt (note 5) 4,699  749  3,950  — 
Fair value measurements at December 31, 2020 using
(in millions) Total Quoted prices
in active
markets for
identical
assets
(Level 1)		 Significant
other
observable
inputs
(Level 2)		 Significant
unobservable
inputs
(Level 3)
Current assets:
Cash equivalents $ 240  240  —  — 
Financial instrument asset (note 5)
 23  23  — 
Current liabilities:
Debt (note 5) 393  —  393  — 
Long-term liabilities:
Debt (note 5) 4,705  743  3,962  — 
 Interest rate swap arrangements (note 5) 3  —  3  —